Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
The firm is engaging with regulators about its recently validated Ataraxis Breast test, which it hopes to make available for clinical use next year.
Becton Dickinson's HPV assay was FDA-approved for use with clinician-collected samples in 2018 and received approval for sample self-collection in May.
Advanced Genomics APAC, 3BIGS Partner on Cancer Testing in Asia-Pacific
The firms will bring together Advanced Genomics APAC's genomic profiling workflow and 3BIGS's bioinformatics capabilities.
Prenetics Q3 Revenues up 59 Percent
The company's CircleDNA and ACT Genomics businesses are on track to achieve business-unit breakeven in the second half of 2024, it said.
Exact Sciences Shares Rise on Unexpected Reimbursement Rate From CMS for Next-Gen Cologuard Test
The next-generation version of the Cologuard test received FDA approval last month and is expected to launch next year.